These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17305567)

  • 21. Effects of combined application of muscle relaxants and celecoxib administration after total knee arthroplasty (TKA) on early recovery: a randomized, double-blind, controlled study.
    Gong L; Dong JY; Li ZR
    J Arthroplasty; 2013 Sep; 28(8):1301-5. PubMed ID: 23561916
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antitumor effects of inhibitors of nitric oxide synthase or cyclooxygenase-2 on human KB carcinoma cells overexpressing COX-2.
    Ohtsu N; Takaoka K; Segawa E; Hashitani S; Noguchi K; Kishimoto H; Urade M
    Oncol Rep; 2010 Jul; 24(1):31-6. PubMed ID: 20514441
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cyclooxygenase-2 inhibitor celecoxib and alveolar osteitis.
    Al-Sukhun J; Penttilä H
    J Ir Dent Assoc; 2011; 57(1):50-3. PubMed ID: 21413548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The post-operative analgesic efficacy of celecoxib compared with placebo and parecoxib after total hip or knee arthroplasty.
    Ittichaikulthol W; Prachanpanich N; Kositchaiwat C; Intapan T
    J Med Assoc Thai; 2010 Aug; 93(8):937-42. PubMed ID: 20718170
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of different loading dose of celecoxib on postoperative anti-inflammation and analgesia in patients undergoing endoscopic nasal surgery-200 mg is equivalent to 400 mg.
    Zhao H; Feng Y; Wang Y; Yang B; Xing Z
    Pain Med; 2011 Aug; 12(8):1267-75. PubMed ID: 21812904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The anti-proliferative potency of celecoxib is not a class effect of coxibs.
    Schiffmann S; Maier TJ; Wobst I; Janssen A; Corban-Wilhelm H; Angioni C; Geisslinger G; Grösch S
    Biochem Pharmacol; 2008 Jul; 76(2):179-87. PubMed ID: 18547544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COX-2 inhibitors and pain after oral surgery - pertinent papers 2002-2003.
    Meechan J
    Br J Oral Maxillofac Surg; 2006 Apr; 44(2):163-5. PubMed ID: 16191457
    [No Abstract]   [Full Text] [Related]  

  • 28. Valdecoxib: a review of its use in the management of osteoarthritis, rheumatoid arthritis, dysmenorrhoea and acute pain.
    Fenton C; Keating GM; Wagstaff AJ
    Drugs; 2004; 64(11):1231-61. PubMed ID: 15161329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The new COX-2 inhibitors: rofecoxib (Vioxx) and celecoxib (Celebrex).
    Wynn RL
    Gen Dent; 2000; 48(1):16-20. PubMed ID: 11199547
    [No Abstract]   [Full Text] [Related]  

  • 30. The efficacy of rebamipide add-on therapy in arthritic patients with COX-2 selective inhibitor-related gastrointestinal events: a prospective, randomized, open-label blinded-endpoint pilot study by the GLORIA study group.
    Hasegawa M; Horiki N; Tanaka K; Wakabayashi H; Tano S; Katsurahara M; Uchida A; Takei Y; Sudo A
    Mod Rheumatol; 2013 Nov; 23(6):1172-8. PubMed ID: 23306427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Celecoxib Analogues for Cancer Treatment: An Update on OSU-03012 and 2,5-Dimethyl-Celecoxib.
    Sobolewski C; Legrand N
    Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The use of celecoxib and dexamethasone for the prevention and control of postoperative pain after periodontal surgery.
    Pilatti GL; André dos Santos F; Bianchi A; Cavassim R; Tozetto CW
    J Periodontol; 2006 Nov; 77(11):1809-14. PubMed ID: 17076604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celecoxib and rofecoxib. The role of COX-2 inhibitors in dental practice.
    Moore PA; Hersh EV
    J Am Dent Assoc; 2001 Apr; 132(4):451-6. PubMed ID: 11315375
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study.
    Cheung R; Krishnaswami S; Kowalski K
    Clin Ther; 2007; 29 Suppl():2498-510. PubMed ID: 18164917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The second generation of COX-2 inhibitors: what advantages do the newest offer?
    Stichtenoth DO; Frölich JC
    Drugs; 2003; 63(1):33-45. PubMed ID: 12487621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cox-2 inhibitors: today and tomorrow.
    McMurray RW; Hardy KJ
    Am J Med Sci; 2002 Apr; 323(4):181-9. PubMed ID: 12003372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Celecoxib in a 12-year-old boy with familial adenomatous polyposis.
    Pérez-Segura P; Bodas A; Sereno M; Martínez-Amores B; Olivera H; Díaz S; López-Asenjo JA; Puente J; Maluenda C; Díaz-Rubio E
    Int J Clin Pharmacol Ther; 2010 Mar; 48(3):230-2. PubMed ID: 20197018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Multimodal effect of celecoxib on the perioperative analgesia in orthopaedic surgery].
    Lu X; Li K
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Aug; 34(8):815-9. PubMed ID: 19734595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. More pronounced inhibition of cyclooxygenase 2, increase in blood pressure, and reduction of heart rate by treatment with diclofenac compared with celecoxib and rofecoxib.
    Hinz B; Dormann H; Brune K
    Arthritis Rheum; 2006 Jan; 54(1):282-91. PubMed ID: 16385545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperexpression of cyclooxygenase 2 in the lupus immune system and effect of cyclooxygenase 2 inhibitor diet therapy in a murine model of systemic lupus erythematosus.
    Zhang L; Bertucci AM; Smith KA; Xu L; Datta SK
    Arthritis Rheum; 2007 Dec; 56(12):4132-41. PubMed ID: 18050205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.